SCHEMBL2913178

SCHEMBL2913178

CC1(C(N)=O)CCCCC1c1ccccc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.44
TDP1 Q9NUW8 1/20 0.44
RBP4 P02753 8/20 0.40
HDAC4 P56524 1/20 0.39
HTR2C P28335 2/20 0.38
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GLA P06280 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6472117 0.81 GAA (0.41) GAATDP1RBP4HDAC4HTR2C
SCHEMBL5906965 0.79 CETP (0.40) GAAHPGDMAPK1CYP3A4MAPT
SCHEMBL4991857 0.74 GAA (0.46) GAATDP1RBP4HDAC4HTR2C
SCHEMBL32690457 0.72 KDM1A (0.44) CYP3A4
SCHEMBL2437373 0.70 KDM4E (0.43) KDM4EALDH1A1MEN1CYP3A4CYP2C9
SCHEMBL2913172 0.69 HDAC4 (0.48) GAATDP1HDAC4KDM4EALDH1A1
SCHEMBL6472112 0.67 HDAC4 (0.45) GAAHDAC4KDM4EALDH1A1MAPK1
SCHEMBL2431727 0.66 PDK1 (0.32) MAPK1CYP3A4CYP2D6
SCHEMBL29399304 0.66 RBP4 (0.38) GAATDP1RBP4HTR2CKDM4E
SCHEMBL5695498 0.66 GAA (0.42) GAATDP1RBP4HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2214487-A1 NOVEL SEH INHIBITORS AND THEIR USE GlaxoSmithKline LLC (US) 2010-08-11 EP disclosed
WO-2009049157-A1 NOVEL SEH INHIBITORS AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2009-04-16 WO disclosed